Skip to content
★ Sign in to follow
Carl Zeiss Meditec AG logo

Carl Zeiss Meditec AG Stock: price and insider trades · Germany

ISIN DE0005313704DE·Mcap €2.8BHealth Care

2 insiders bought €124k of shares over the last 90 days, the latest by Pecher, Andreas, filed 10 Sept 2026.

Carl Zeiss Meditec AG: what insiders have been doing

This page follows insider dealings at Carl Zeiss Meditec AG as filed with BaFin, a company from the Health Care sector based in Jena, Germany. The group dates from 2002. In the past year (9 November 2025 to 9 November 2026), 3 filings came from 3 insiders.

No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €176k, made by 3 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €104k, the purchase published on 7 September 2026 by Wehmer, Justus Felix is the largest of the period (0.0033% of market cap). Those buying include 2 senior executives and 1 board member.

In the case of 1 purchase, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 10 September 2026, 59 days ago. Between a trade and the moment it shows up on BaFin, the median delay is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19).

Compared with its exchange (290 companies, median 5 filings), a count of 3 filings is below the norm. Since 2026, the database holds 3 purchases and no sales by insiders of the company.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from BaFin. Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
€175,606
3 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Andreas Pecher1 buy
Justus Felix Wehmer1 buy
Peter Kameritsch1 buy

Since the insiders bought

  • Filed 10 Sept 2026 · 59 days ago · €20k
    +6.6%
    Entry €30.50 · Close 12 Oct 2026 €32.50
  • Filed 07 Sept 2026 · 62 days ago · €104k
    +5.6%
    Entry €30.78 · Close 12 Oct 2026 €32.50
  • Filed 28 May 2026 · 164 days ago · €52k
    +24.9%
    Entry €26.02 · Close 12 Oct 2026 €32.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Carl Zeiss Meditec AG Underperform (bearish), based on 15 analysts. Average price target: €26.89.

Fundamental score
Ranked 7,601 of 26,911 companies
62.5
score / 100
Value
61
Quality
64
FCF yld4.4%
Earn yld4.6%
EV/EBITDA9.2x
ROE4.5%
Gross mgn53%
Net mgn6.3%
Debt/EBITDA0.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended September 2025 · cache

€32.50
Analyst consensus
15 analysts
Underperform
€18.10Target €26.89(-17%)€35.00
Income statement
Revenue€2.2B
Gross profit€1.2B53% margin
EBITDA€346.9M16% margin
Net income€141.2M5.6% margin
Valuation
PER (trailing)23.2x
PER (forward)22.3x
P/Book1.4x
Beta1.33
Balance sheet & cash
Market cap€2.8B
Total debt€132.5M
Free Cash Flow€133.3M
Debt / Equity28%
Profitability & ownership
ROE4.5%
ROA2.7%
% insiders59.1%
% institutions19.8%
Last declaration on 10 September 2026
Declarations3 total
  • ▲
    Management BoardExecutives
    €20k33BaFin
    656 shares@ €30.850.0007% mcap100.0% of flowShareTradegateISIN DE0005313704BAFIN:40002012-66d0ad8ec8b4
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    Management BoardExecutives
    €104k21BaFin
    3,199.52 shares@ €32.370.0038% mcap100.0% of flowShareXETRAISIN DE0005313704BAFIN:40002012-3027e3e79834
    Canonical exit: 3 Dec 2026 (T+90)
  • ▲
    Supervisory boardExecutives
    €52k15BaFin
    2,000 shares@ €25.90100.0% of flowShareXetraISIN DE0005313704BAFIN:40002012-d3f88076c8c2
    Canonical exit: 26 Aug 2026 (T+90)

3 of 3 declarations

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a company specializing in medical technology, providing innovative solutions for the diagnosis and treatment of eye diseases. It is listed on the Frankfurt Stock Exchange (XETR).